Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
Walgreens Boots Alliance (WBA) serves as a global leader in pharmacy-led healthcare and retail innovation. This news hub provides investors and industry professionals with essential updates on strategic initiatives, financial performance, and operational developments shaping this Fortune 500 company.
Access official press releases and curated analysis covering pharmacy services expansion, healthcare partnerships, and retail optimization strategies. Our repository includes updates on prescription care programs, wholesale distribution milestones, and regulatory developments impacting WBA's international operations.
Key categories include quarterly earnings disclosures, leadership changes, store network updates, and technological advancements in pharmaceutical distribution. Bookmark this page for streamlined tracking of WBA's progress in merging community pharmacy care with modern health solutions across 25+ countries.
Walgreens Boots Alliance (Nasdaq: WBA) will announce its fiscal 2024 third-quarter results on June 27, 2024. The results will be released at 7 a.m. ET, followed by a conference call with WBA management at 8:30 a.m. ET.
The call will be simulcast on the WBA investor relations website and a replay will be available for 12 months.
Walgreens has announced a new wave of price reductions, extending their commitment to help customers save on over 1,300 products across various categories. This initiative follows similar efforts started in October 2023. Key price drops include Eucerin Advance Repair Hand Cream (now $5.99, down from $7.29) and Nice! Mini Pretzels (now $1.99, down from $2.79).
Additionally, Walgreens will reintroduce its myW Days promotional campaign in mid-July, offering personalized deals to its 110 million loyalty program members. These measures are designed to alleviate financial pressures on consumers and improve access to essential items.
Walgreens is launching its inaugural community health fair, “Walgreens en tu Comunidad,” in San Juan, Puerto Rico on June 8. The event aims to enhance access to health services and education, featuring health screenings, vaccinations, and various health-related activities. Key offerings include free HIV testing, blood pressure screenings, and routine immunizations. The fair will also provide CPR demonstrations and health education from the American Heart Association, prenatal vitamins from Vitamin Angels, and consultations from Walgreens beauty and wellness experts. Special guests include Puerto Rico senator Nitza Moran Trinidad and Walgreens' chief customer officer, Tracey Brown. The event will be held from 10 a.m. to 4 p.m. ET at the Walgreens store in Montehiedra.
Walgreens celebrated Clinical Trials Day with an event in Boston highlighting women's health in clinical trials and healthcare innovation. Kendal Whitlock, head of digital optimization for Walgreens Clinical Trials, emphasized raising awareness about gender-specific health disparities and the importance of women's participation in medical research. Keynote speakers, including Walgreens Chief Clinical Trials Officer Ramita Tandon and Dr. Yvette Cozier, shared insights on increasing women's involvement in clinical trials. Walgreens announced a new clinical trials center in Malden and highlighted milestones, such as reaching over 4 million potential trial participants with over 60% being women.
Walgreens Boots Alliance (WBA) has sold approximately $400 million worth of Cencora (COR) shares through a stock repurchase agreement, decreasing its ownership from 13% to 12%.
The proceeds will be used mainly for debt reduction and general corporate purposes, supporting WBA's strategy to enhance its health services rooted in retail pharmacy.
The sale does not affect the ongoing collaboration or long-term strategic partnership between the companies. Ornella Barra, COO International of WBA, will continue to serve on Cencora's Board of Directors.
Walgreens has announced the launch of its over-the-counter Walgreens Brand Naloxone HCl Nasal Spray, effective in reversing opioid overdoses.
Retailing at $34.99, it is a more affordable option compared to the national brand. Initially available online, it will be in all stores by the end of the month. This initiative aims to improve access to naloxone, potentially lowering the impact of the opioid epidemic in the U.S.
Dr. Priya Mammen, Senior Medical Director at Walgreens, emphasized the importance of this move in combating opioid overdoses. The product has received approval from the U.S. Food and Drug Administration.
Walgreens is honoring veterans, active-duty military personnel, and their families with a Memorial Day weekend discount from May 24 to May 27. Eligible customers with a myWalgreens® membership and valid military ID or proof of service will receive a 20% discount on regularly priced products at any Walgreens or Duane Reade stores nationwide. Exclusions apply, including alcohol, dairy, tobacco, and prescription items. The myWalgreens® membership is free and available at checkout. This initiative underscores Walgreens' commitment to supporting the military community.
Walgreens partners with Dion's Chicago Dream to address food insecurity in the Chicagoland area by providing fresh produce to over 275 households and 1,000 residents weekly for a year. The collaboration aims to improve health outcomes, create jobs, and promote health equity.
Walgreens is enhancing its specialty pharmacy services by introducing Walgreens Specialty Pharmacy, which includes Gene and Cell Services Pharmacy and Innovation Center. The company aims to improve patient outcomes, provide value to payers, and leverage its neighborhood pharmacies into growing healthcare areas. Walgreens Specialty Pharmacy offers a wide range of services, including gene and cell therapy, central specialty pharmacies, community-based specialty pharmacies, specialty-trained pharmacists, patient advocacy support, and distribution drugs. The company is focused on breaking through healthcare silos and providing comprehensive care to help payers manage specialty costs. With $24 billion in annual enterprise specialty revenue, Walgreens Specialty Pharmacy is the largest independent provider in the U.S. The company is committed to an integrated care model to serve patients effectively.
DoorDash and Walgreens have teamed up to offer SNAP customers the ability to make purchases at Walgreens using their SNAP/EBT cards. DoorDash is the first platform to enable SNAP customers to buy directly from Walgreens, expanding food access for millions of individuals living in food deserts or SNAP/EBT communities. This partnership provides convenient access to over 4,000 SNAP-eligible products for delivery within an hour through DoorDash, helping consumers fulfill their grocery needs quickly and affordably.